Publikasjonar

Nøkkelpublikasjonar fra Mohn Kreftforskingslaboratorium

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.
Knappskog S, Lønning PE.

The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.
Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS, Stoltenberg C, Romundstad P, Hveem K, Lillehaug JR, Vatten L, Devilee P, Dørum A, Lønning PE.


 

Siste publikasjonar


Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.​

Lønning PE1, Haynes BP2, Dowsett M3.

Signatures of mutational processes in human cancer.
Alexandrov LB, ....................Knappskog S,..............

Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.
Lønning PE, Knappskog S.

Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC, Wagner M, Straume O, Bjerkvig R, Eikesdal HP.
Expert Opin Ther Targets. 2013 Jan;17(1):7-20. doi: 10.1517/14728222.2013.730522. Epub 2012 Nov 2.


Lethal pneumonitis after docetaxel chemotherapy: Case report and review of the literature.
Storaas E, Holmaas G, Gravdal K, Børretzen A, Eikesdal HP.
Acta Oncol. 2012 Dec 17. [Epub ahead of print]

Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Kvalheim G, Lonning PE, Naume B.Breast Cancer Res. 2012 

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.
Schuster C, Eikesdal HP, Puntervoll H, Geisler J, Geisler S, Heinrich D, Molven A, Lønning PE, Akslen

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions.
Lønning PE. Ther Adv Med Oncol. 2012 May;4(3)​​:127-37. PMID: 22590486 [PubMed - in process]

Publikasjonar pr år

 

 


Fann du det du leita etter?
Tilbakemeldinga vil ikkje bli svart på. Ikkje send personleg informasjon, for eksempel e-post, telefonnummer eller personnummer.